Thursday, March 19, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Dividends

Tetra Tech Raises Guidance Following Strong Quarterly Performance

Dieter Jaworski by Dieter Jaworski
February 1, 2026
in Dividends, Earnings, Industrial
0
Tetra Tech Stock
0
SHARES
7
VIEWS
Share on FacebookShare on Twitter

Tetra Tech has commenced its new fiscal year with significant momentum, delivering first-quarter results that comfortably surpassed market expectations. The company’s robust profitability and substantial backlog have prompted management to issue an upgraded outlook for the full year.

Financial Highlights Exceed Expectations

The engineering and consulting firm reported adjusted earnings per share of $0.35 for the quarter, outperforming the consensus estimate of $0.31. Net revenue reached $1.04 billion, representing an 8% increase on an adjusted basis and exceeding the company’s own projected range of $950 million to $1 billion.

A strategic emphasis on high-value consulting and engineering services drove substantial margin improvement. The adjusted EBITDA margin expanded by 140 basis points year-over-year to 14.2%, underscoring strong operational execution.

Upgraded Full-Year Forecast

In response to this operational strength, Tetra Tech’s leadership has raised its financial targets for fiscal 2026. The company now anticipates full-year revenue in the range of $4.15 billion to $4.30 billion. Adjusted earnings per share are projected to land between $1.46 and $1.56.

For the ongoing second quarter, the company is targeting net revenue of $975 million to $1.025 billion.

Should investors sell immediately? Or is it worth buying Tetra Tech?

Record Contract Awards Fuel Backlog Growth

Long-term visibility has been enhanced by several major contract wins. A key achievement was the award for the U.S. Missile Defense Agency’s SHIELD program—a ten-year, indefinite-delivery/indefinite-quantity contract with a potential ceiling of $151 billion. Additionally, the company secured a $500 million contract for environmental services within the United States. These awards contributed to a total backlog of $3.95 billion at the quarter’s close.

Shareholders are directly benefiting from the company’s performance. The board of directors authorized a 12% increase in the quarterly cash dividend to $0.065 per share. This enhanced dividend is payable on February 27. Concurrently, Tetra Tech repurchased $50 million worth of its own shares during the first quarter.

Geographic and Segment Performance

International operations remain robust, with activities in the United Kingdom, Australia, and Canada now contributing 48% of net revenue. Segment performance showed balanced growth: the government services group reported a 5% increase, while the commercial and international clients segment grew by 10%.

Looking ahead, a leadership transition is scheduled for the coming quarter. Following the annual meeting, designated Chief Executive Officer Roger Argus will assume leadership. His focus will include further expanding the data analytics division, which has been bolstered by recent acquisitions.

Ad

Tetra Tech Stock: Buy or Sell?! New Tetra Tech Analysis from March 18 delivers the answer:

The latest Tetra Tech figures speak for themselves: Urgent action needed for Tetra Tech investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from March 18.

Tetra Tech: Buy or sell? Read more here...

Tags: Tetra Tech
Dieter Jaworski

Dieter Jaworski

About Dieter Jaworski From a numbers-obsessed child to creating his first investment newsletter. Even as a child, Dieter Jaworski's mother couldn't believe how fascinated he was with numbers. This early passion for mathematics and data analysis laid the foundation for a successful career in financial markets and investment analysis.
Areas of Expertise:
  • Quantitative Analysis
  • Financial Newsletter Publishing
  • Data-Driven Investment Strategies
  • Market Pattern Recognition
Dieter's unique approach combines his natural affinity for numbers with decades of market experience, providing investors with data-driven insights and practical investment strategies.

Related Posts

VERSAMET Stock
Commodities

Versamet Posts Record Financial Performance in 2025

March 18, 2026
Merchants Trust - 3.65% Prf Perpetual Gbp 1 Stock
Analysis

Merchants Trust Publishes Latest Net Asset Value Figures

March 18, 2026
Infineon Stock
Asian Markets

Infineon’s Strategic Pivot Amid Rising Asian Competition in Power Semiconductors

March 18, 2026
Next Post
AutoNation Stock

AutoNation's Upcoming Earnings: A Test of Resilience in a Shifting Market

Bio-Rad Laboratories Stock

Bio-Rad Laboratories: A Preview of the Upcoming Financial Report

Synopsys Stock

Synopsys Earnings Report Takes Center Stage for Investors

Recommended

aTyr Pharma Stock

Clinical Trial Failure Sends aTyr Pharma Shares into Freefall

6 months ago
Pepsi Stock

Activist Investor Elliott Takes $4 Billion Stake in PepsiCo, Demands Strategic Overhaul

6 months ago
Melco Resorts, Entertainment Stock

Melco Resorts’ Strategic Pivot Fuels Impressive Stock Surge

3 months ago
Storefront

How to Find an Amazon Storefront: A Comprehensive Guide

3 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Salesforce Strategy Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

A Pivotal Tax Change Looms for Bitcoin Staking ETP Investors

InMed Pharmaceuticals: The Critical Search for Clinical Validation

Merchants Trust Publishes Latest Net Asset Value Figures

Traverse Energy: A Company in Strategic Limbo

Nel ASA Embraces Digital Shift with Virtual Annual Meeting

Infineon’s Strategic Pivot Amid Rising Asian Competition in Power Semiconductors

Trending

PPI Shock, $109 Brent, and the Afternoon Powell Has No Good Answers
Newsletter

PPI Shock, $109 Brent, and the Afternoon Powell Has No Good Answers

by Stephanie Dugan
March 18, 2026
0

Dear readers, Yesterday we told you the equity market's composure rested on a bet that demanded near-perfect...

Advance United Holdings Stock

Strengthening Market Presence: Advance United Holdings Engages Liquidity Provider

March 18, 2026
VERSAMET Stock

Versamet Posts Record Financial Performance in 2025

March 18, 2026
1valour Btc Physical Staking Stock

A Pivotal Tax Change Looms for Bitcoin Staking ETP Investors

March 18, 2026
InMed Pharmaceuticals Stock

InMed Pharmaceuticals: The Critical Search for Clinical Validation

March 18, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • PPI Shock, $109 Brent, and the Afternoon Powell Has No Good Answers
  • Strengthening Market Presence: Advance United Holdings Engages Liquidity Provider
  • Versamet Posts Record Financial Performance in 2025

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com